Brands and Their Owners
Welcome to the Brand page for “I-DART”, which is offered here for Production and product commercialization for third parties of pharmaceuticals and substances, polypeptides, antibodies and antibody derivatives, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases;discovery, research, development, engineering and testing of pharmaceuticals and substances, polypeptides, antibodies and antibody derivatives, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases; providing medical and scientific research information relating to pharmaceutical substances, polypeptides, antibodies and antibody derivatives, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases;.
Its status is currently believed to be active. Its class is unavailable. “I-DART” is believed to be currently owned by “MACROGENICS, INC.”
Owner: |
MACROGENICS, INC.
Owner Details |
---|---|
Description: |
Production and product commercialization for third parties of pharmaceuticals and substances, polypeptides, antibodies and antibody derivatives, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases;Discovery, research, development, engineering and testing of pharmaceuticals and substances, polypeptides, antibodies and antibody derivatives, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases; Providing medical and scientific research information relating to pharmaceutical substances, polypeptides, antibodies and antibody derivatives, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases;
|
Categories: | PRODUCTION PRODUCT COMMERCIALIZATION |